Literature DB >> 27839720

Anhedonia and its correlation with clinical aspects in Parkinson's disease.

Hiroshi Nagayama1, Tetsuya Maeda2, Tsuyoshi Uchiyama3, Masaya Hashimoto4, Nobuatsu Nomoto5, Osamu Kano6, Tatsuya Takahashi7, Hiroo Terashi8, Shinsuke Hamada9, Takafumi Hasegawa10, Taku Hatano11, Tetsuya Takahashi12, Yasuhiko Baba13, Renpei Sengoku14, Hirohisa Watanabe15, Manabu Inoue16, Taro Kadowaki17, Satoshi Kaneko18, Hideki Shimura19, Shin-Ichiro Kubo11.   

Abstract

Anhedonia is one of the non-motor symptoms observed in the Parkinson's disease (PD). However, there is no clear relationship between anhedonia and its correlation with other symptoms of PD. The aim of this study is to evaluate the characteristics of anhedonia and its correlation with clinical aspects of PD in a relatively large cohort. We enrolled 318 patients with PD and 62 control subjects for this study. Patients and subjects were tested using the Snaith-Hamilton Pleasure Scale Japanese version and the Beck Depression Inventory 2nd edition for the assessment of anhedonia and depression. We also investigated the correlation among clinical aspects of PD, anhedonia, and depression in patients with PD. The Snaith-Hamilton Pleasure Scale Japanese version and the Beck Depression Inventory 2nd edition scores were significantly higher in patients with PD than in control subjects (p=0.03 and p=0.0006, respectively). All PD patients with anhedonia had a significantly higher score on the unified Parkinson's disease rating scale (UPDRS) parts I and II compared to PD patients without anhedonia. Additionally, all PD patients with depression scored significantly higher on UPDRS part I-IV than PD patients without depression. The patients with anhedonia and without depression had mild motor severity and their treatment was relatively low dosage. These results suggest that anhedonia and depression are slightly linked, but not the same. PD patients with only anhedonia may be closely linked apathy found in untreated early stages of PD.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anhedonia; Depression; Parkinson's disease; Snaith–Hamilton Pleasure Scale

Mesh:

Year:  2016        PMID: 27839720     DOI: 10.1016/j.jns.2016.10.051

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Psychometric properties the of Brazilian Portuguese version of Snaith-Hamilton Pleasure Scale (SHAPS).

Authors:  Ana Paula Jesus-Nunes; João Paulo Barreto Borges Coroa; Felipe Coelho Argolo; Tayne de Miranda Moreira; Mychelle Morais-de-Jesus; Roberta Ferrari Marback; Fernanda S Correia-Melo; Acioly L T Lacerda; Lucas C Quarantini
Journal:  Trends Psychiatry Psychother       Date:  2021-01-22

Review 2.  Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression.

Authors:  Yena Lee; Mehala Subramaniapillai; Elisa Brietzke; Rodrigo B Mansur; Roger C Ho; Samantha J Yim; Roger S McIntyre
Journal:  Ther Adv Psychopharmacol       Date:  2018-11-19

Review 3.  Anhedonia in Neurodegenerative Diseases.

Authors:  Vicky Turner; Masud Husain
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Non-Motor Symptoms of Parkinson's Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction.

Authors:  Ayan Hussein; Christopher A Guevara; Pamela Del Valle; Swati Gupta; Deanna L Benson; George W Huntley
Journal:  Neuroscientist       Date:  2021-05-08       Impact factor: 7.235

5.  Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP).

Authors:  Hongyan Ren; Chiara Fabbri; Rudolf Uher; Marcella Rietschel; Ole Mors; Neven Henigsberg; Joanna Hauser; Astrid Zobel; Wolfgang Maier; Mojca Z Dernovsek; Daniel Souery; Annamaria Cattaneo; Gerome Breen; Ian W Craig; Anne E Farmer; Peter McGuffin; Cathryn M Lewis; Katherine J Aitchison
Journal:  Transl Psychiatry       Date:  2018-08-13       Impact factor: 6.222

6.  Apathy and the Risk of Predementia Syndromes in Community-Dwelling Older Adults.

Authors:  Mirnova E Ceïde; Alana Warhit; Emmeline I Ayers; Gary Kennedy; Joe Verghese
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-08-13       Impact factor: 4.077

7.  Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine.

Authors:  Hirohisa Watanabe; Tatsuya Hattori; Akito Kume; Kenichiro Misu; Takashi Ito; Yu Koike; Todd A Johnson; Shigeo Kamitsuji; Naoyuki Kamatani; Gen Sobue
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.